Delivery Order SPE2DB20D2014-SPE2DB25FA25A

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024. The contract has a firm fixed price of $2,359.95 and an ultimate completion date of December 31, 2024. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a medication used in the treatment of Parkinson's disease. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,237.14, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules, a medication used in the treatment of Parkinson's disease. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. This award is not associated with a set-aside designation....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,690.35 contract is for the supply of RYTARY ER 36.25 MG-145 MG capsules, a medication used for the treatment of Parkinson's disease. The contract has an ultimate completion date of June 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription medication. The contract has a ceiling value of $2,680.50 and a period of performance through January 7, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, with a ceiling value of $7,529.70 and an ultimate completion date of May 17, 2023. The contract type is Firm Fixed Price. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $6,211.66 and has a completion date of September 25, 2023. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules in 100-count bottles. This contract was awarded as part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication, with a ceiling value of $17,088.91. The contract is a firm fixed-price delivery order and is not set aside for any special designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 48.75 mg to 195 mg capsules of the medication RYTARY ER, with a total ceiling value of $3,618.48. The contract is a firm fixed price delivery order, with a period of performance through May 19, 2025. This contract is not set aside for any specific business type. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,761.74, is for the delivery of 4567117581 RYTARY ER 48.75 MG-195 MG capsules in lots of 100. The contract is a Firm Fixed Price type, with a period of performance through February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,266.49, is for the delivery of RYTARY ER 23.75 MG-95 MG capsules in quantities of 100. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 4, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA25A
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a medication used to treat Parkinson's disease. The contract has a ceiling value of $3,922.44 and runs through November 4, 2024. The contract is a Firm Fixed Price (FFP) type and is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 1:43 PM